CAS 163521-08-2 Purity >99.0% (HPLC) API High Purity

Short Description:

CAS: 163521-08-2

Purity: >99.0% (HPLC)

Appearance: White or Off-White Powder

Potent 5-HT1A Partial Agonist and SSRI; Antidepressant

API High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Manufacturer Supply Related Intermediates
5-Cyanoindole CAS 15861-24-2
3-(4-Chlorobutyl)-5-Cyanoindole CAS 143612-79-7
Ethyl 5-Nitrobenzofuran-2-Carboxylate CAS 69604-00-8
Ethyl 5-Aminobenzofuran-2-Carboxylate CAS 174775-48-5
5-(Piperazin-1-yl)benzofuran-2-Carboxamide CAS 183288-46-2
CAS 163521-08-2

Chemical Properties:

Synonyms	5-[4-[4-(5-Cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2-Carboxamide Hydrochloride
CAS Number	163521-08-2
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C26H28ClN5O2
Molecular Weight	477.98582
Melting Point	279℃ (lit.)
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	White or Off-White Powder
Identification	By IR; By HPLC
Water Content	<1.00%
Residue on Ignition	<0.10%
Heavy Metals	<20ppm
Related Substances
Any Single Impurity	<0.50%
Total Impurities	<1.00%
Purity / Analysis Method	>99.0% (HPLC) (on the anhydrous basis)
Test Standard	Enterprise Standard
Usage	API; For the treatment of Major Depressive Disorder (MDD); Antidepressant

Package & Storage:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture

Advantages:

FAQ:

Application:

API (CAS: 163521-08-2) is a combined serotonin specific reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist for the treatment of Major Depressive Disorder (MDD). Antidepressant. It is marketed under the trade name Viibryd, was developed by Merck KGaA (Germany) and approved for the treatment of depression by the U.S. FDA on January 21st, 2011. It has been shown to be well-tolerated at higher dosage levels, specifically by not causing significant weight gain or decreased sexual desire or function, which are improvements over existing antidepressant treatments. Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of it and related intermediates with high quality.